It has been about a month since the last earnings report for HealthEquity (HQY) . Shares have lost about 4.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is HealthEquity due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. HealthEquity Q2 Earnings & Revenues Beat E ...

DRAPER, Utah, Oct. 03, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity"), the leader in Health Savings Account (HSA) and consumer-directed benefits administration, today announced the launch of its new HealthEquity Community Foundation. Dedicated to building healthcare literacy and confidence in communities across the United States, the Foundation's initial focus will be on providing grants to nonprofit charitable organizations. "For over two decades, HealthEquity teammates have wor ...

HealthEquity, Inc. (HQY) has been gaining from its business model and strategy. The optimism led by a solid second-quarter fiscal 2025 performance and strength in Health Savings Accounts (HSA) are expected to contribute further. However, data security issues and macro challenges are major downsides. Over the past six months, this Zacks Rank #2 (Buy) stock has gained 0.3% against the industry's 2.5% decline and the S&P 500's 10.2% rise. The renowned provider of technology-enabled services platforms for healt ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end. However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Sco ...

Core Viewpoint - HealthEquity (HQY) shows potential for significant upside, with a mean price target of $104.71 indicating a 32.9% increase from the current trading price of $78.80 [1] Price Targets - The mean estimate consists of 14 short-term price targets with a standard deviation of $5.22, suggesting a consensus among analysts [2] - The lowest estimate of $95 indicates a 20.6% increase, while the highest estimate of $115 suggests a potential surge of 45.9% [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [7] Analyst Sentiment - Analysts are optimistic about HQY's earnings prospects, as indicated by upward revisions in earnings estimates [9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.9%, with no negative revisions [10] - HQY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] Caution on Price Targets - Price targets can mislead investors, as empirical research shows they rarely indicate actual stock price movements [5] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [6] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [8]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores are designed to help investors identify stocks with the potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores categorize stocks into four main types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4] - Value Score emphasizes finding undervalued stocks using financial ratios [3] - Growth Score assesses a company's financial health and future growth potential [3] - Momentum Score capitalizes on price trends and earnings outlook changes [4] - VGM Score combines all three styles to identify stocks with the best overall characteristics [4] Zacks Rank and Performance - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors in stock selection [5] - Stocks rated 1 (Strong Buy) have historically outperformed the S&P 500, achieving an average annual return of +25.41% since 1988 [6] - There are over 800 stocks rated 1 or 2, making it essential for investors to choose wisely [6] Stock Selection Strategy - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal success [7] - The direction of earnings estimate revisions is crucial in stock selection, as downward trends can indicate potential price declines [8] Company Spotlight: HealthEquity (HQY) - HealthEquity, based in Draper, UT, specializes in health-care account management solutions [9] - HQY holds a Zacks Rank of 2 (Buy) and has a VGM Score of A, indicating strong potential [9] - The stock has a Momentum Style Score of A, with a 5.1% increase in share price over the past four weeks [10] - Recent upward revisions in earnings estimates for fiscal 2025 have increased the Zacks Consensus Estimate by $0.08 to $3.08 per share, with an average earnings surprise of 19.8% [10]

Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Sty ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end. However, it's pretty easy to find cutting-edge growth stocks w ...

HealthEquity (HQY) closed the last trading session at $76.24, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $104.14 indicates a 36.6% upside potential. The average comprises 14 short-term price targets ranging from a low of $92 to a high of $115, with a standard deviation of $6.14. While the lowest estimate indicates an increase of 20.7% from the current price level, ...

Core Viewpoint - HealthEquity (HQY) has announced a collaboration with Paytient to enhance access to healthcare for working professionals through Health Payment Accounts (HPAs) [1][2]. Group 1: Partnership and Benefits - The partnership is expected to improve access to healthcare for employees by offering HPAs, which provide a no-interest, no-fee option for medical care with flexible payment terms [2][3]. - HPAs will allow employees to manage copays for various types of care, including medical, dental, vision, prescription, and behavioral care, as well as veterinary care [3]. - The HPA benefit complements existing consumer-directed benefits such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Accounts (HRAs) [4]. Group 2: Financial Performance and Projections - HealthEquity reported better-than-expected second-quarter fiscal 2025 results, driven by solid growth in HSAs and an increase in total HSA assets [6]. - The company has revised its revenue projections for fiscal 2025 to between $1.17 billion and $1.19 billion, up from the previous outlook of $1.16 billion to $1.18 billion [7]. - Adjusted EPS is now expected to be in the range of $2.98-$3.14, an increase from the earlier guidance of $2.93-$3.10 [7]. Group 3: Recent Developments - In May, HealthEquity completed the acquisition of Conduent's BenefitWallet HSA portfolio, which is expected to significantly boost service revenues and increase customer accounts [8]. - Over the past six months, HQY shares have gained 22.2%, outperforming the industry’s rise of 6.3% and the S&P 500's gain of 15.6% [9].